000 | 01781 a2200517 4500 | ||
---|---|---|---|
005 | 20250518052545.0 | ||
264 | 0 | _c20200406 | |
008 | 202004s 0 0 eng d | ||
022 | _a1449-2288 | ||
024 | 7 |
_a10.7150/ijbs.35284 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Wenhui | |
245 | 0 | 0 |
_aIlamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2. _h[electronic resource] |
260 |
_bInternational journal of biological sciences _c2019 |
||
300 |
_a1723-1732 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiological Products _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aEndoplasmic Reticulum Stress _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xgenetics |
700 | 1 | _aFang, Huan | |
700 | 1 | _aWu, Qiuju | |
700 | 1 | _aWang, Xinye | |
700 | 1 | _aLiu, Rong | |
700 | 1 | _aLi, Fubin | |
700 | 1 | _aXiao, Ji | |
700 | 1 | _aYuan, Lin | |
700 | 1 | _aZhou, Zhongmei | |
700 | 1 | _aMa, Junying | |
700 | 1 | _aWang, Lulu | |
700 | 1 | _aZhao, Weiwei | |
700 | 1 | _aYou, Hua | |
700 | 1 | _aJu, Jianhua | |
700 | 1 | _aFeng, Jing | |
700 | 1 | _aChen, Ceshi | |
773 | 0 |
_tInternational journal of biological sciences _gvol. 15 _gno. 8 _gp. 1723-1732 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.7150/ijbs.35284 _zAvailable from publisher's website |
999 |
_c29954292 _d29954292 |